Skip to main content
. 2019 Feb 21;8:51–63. doi: 10.1007/s40204-019-0110-0

Fig. 12.

Fig. 12

Photographs of skin on initial day and 12th day: (G1, G1I) control group, (G3, G3I) seed extract, (G4, G4I) flavonoid content, (G5, G5I) Mlf@AuNps, (G7, G7I) Mlf@Au–AgNps, (G6, G6I) Mlf@AgNps, (G2, G2I) reference drug at optimum dose 70mg/g ointment demonstrating progressive decrease in wound size